Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) has issued an announcement.
Sinco Pharmaceuticals Holdings Ltd. has established a Nomination Committee to oversee the appointment and nomination of directors. The committee will consist of at least three members, primarily independent non-executive directors, and will meet at least twice a year. This move aims to enhance corporate governance and ensure a diverse and independent board, potentially strengthening the company’s industry positioning and stakeholder confidence.
The most recent analyst rating on (HK:6833) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Sinco Pharmaceuticals Holdings Ltd. stock, see the HK:6833 Stock Forecast page.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Ltd. is a company incorporated under the laws of the Cayman Islands, operating in the pharmaceutical industry. The company focuses on developing and providing pharmaceutical products and services.
Average Trading Volume: 280,181
Technical Sentiment Signal: Buy
Current Market Cap: HK$496M
Learn more about 6833 stock on TipRanks’ Stock Analysis page.